-
Carbapenemase Genes in CREC: Dynamics, Distribution, and Res
2026-07-18
This study systematically characterizes carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, revealing high prevalence and efficient horizontal transfer of blaNDM-1 on plasmids. The findings highlight multidrug resistance patterns and epidemiological trends, offering crucial insights for antibacterial research and surveillance.
-
CARM1-Targeted Peptide Inhibition Suppresses Breast Cancer P
2026-07-17
This study introduces a selective peptide inhibitor of CARM1, demonstrating potent suppression of breast cancer cell proliferation and tumor growth both in vitro and in vivo. The findings highlight a new therapeutic avenue for overcoming endocrine resistance in hormone receptor-positive breast cancer.
-
PBS Liposomes: Optimal Controls for Macrophage Depletion Stu
2026-07-17
PBS Liposomes offer a gold-standard, biologically inert control for in vivo macrophage depletion protocols, ensuring clear attribution of effects in comparative studies. Their validated uptake and exceptional stability make them indispensable for reproducible immunological research.
-
AMPK Suppresses Autophagy: Revisiting Energy Stress Pathways
2026-07-16
This study redefines the canonical view of AMPK as a promoter of autophagy, demonstrating instead that AMPK inhibits ULK1 and autophagy induction during energy stress. These findings have important implications for experimental strategies targeting autophagy and vesicle trafficking, particularly when interpreting results with selective Vps34 inhibitors.
-
Indole-3-pyruvic Acid: Translational Gateways from Auxin to
2026-07-16
Explore the multifaceted roles of Indole-3-pyruvic acid (IPA) in plant hormone biosynthesis and immune modulation. This in-depth review uniquely bridges molecular mechanisms with translational research, revealing IPA’s distinctive therapeutic potential.
-
Fluo-4 AM Calcium Assay Kit: Empowering Mechanotransduction
2026-07-15
The Fluo-4 AM Calcium Assay Kit brings unprecedented sensitivity and workflow flexibility to live-cell calcium signaling analysis. Its no-wash protocol and robust signal-to-noise ratio make it ideal for advanced mechanotransduction studies and high-throughput GPCR screening, outpacing older UV-excited dyes in both ease and precision.
-
Synergistic Dual OXPHOS Blockade via LRPPRC Inhibition and D
2026-07-15
The reference study defines a novel combination strategy against OXPHOS-dependent tumors by jointly targeting mitochondrial and nuclear-encoded OXPHOS genes through LRPPRC inhibition and dasatinib. This dual-genome approach shows robust anti-tumor activity, offering a mechanistic rationale for combination metabolic therapies in LRPPRC-high cancers.
-
Cy3-UTP: Advancing Fluorescent RNA Labeling for RNA Biology
2026-07-14
Cy3-UTP is redefining fluorescent RNA labeling with unmatched photostability and sensitivity, enabling precise RNA visualization and interaction studies. Discover how APExBIO’s Cy3-UTP streamlines in vitro transcription workflows and empowers new frontiers in RNA-protein interaction and nucleolar architecture research.
-
Imatinib (STI571) Workflows: Precision in Tyrosine Kinase In
2026-07-14
Imatinib (STI571) from APExBIO enables precise, reproducible inhibition of PDGF receptor, c-Kit, and Abl kinases—unlocking advanced signal transduction research and cancer biology workflows. This guide delivers actionable protocols, troubleshooting insights, and data-driven tips for maximizing Imatinib’s impact in kinase-driven experimental systems.
-
Promethazine HCl (SKU B4784): Resolving Lab Assay Challenges
2026-07-13
This article guides biomedical researchers through practical challenges in cell-based and immunological assays, demonstrating how Promethazine HCl (SKU B4784) delivers reliable, reproducible results. Using scenario-driven Q&A, we address experimental design, protocol optimization, and vendor selection, highlighting APExBIO's formulation strengths for host-pathogen interaction research.
-
Applied Dihydrotestosterone (DHT) Workflows for Cancer & ALS
2026-07-13
Dihydrotestosterone (DHT) empowers research in androgen receptor signaling, therapy resistance, and neuromuscular degeneration. This guide details optimized protocols, troubleshooting strategies, and innovative insights—bridging cancer and neurobiology workflows for maximum translational impact.
-
Chlorpromazine HCl: Dopamine Receptor Antagonist for Neuroph
2026-07-12
Chlorpromazine HCl empowers researchers to dissect dopamine signaling and endocytosis mechanisms in neuropharmacology and cancer studies. This guide synthesizes protocol enhancements, troubleshooting strategies, and novel applications—bridging classic antipsychotic pharmacology with modern cellular assay innovation.
-
Heptamethine Cyanine Dye Suppresses Progesterone Receptor in
2026-07-10
This study introduces a tumor-targeted heptamethine cyanine dye (CA800-PR) that selectively suppresses progesterone receptor activity in hormone receptor-positive breast cancer. The findings demonstrate a unique mechanism of Golgi apparatus disruption and selective antitumor immunity, offering a promising direction for future endocrine therapy alternatives.
-
Cycloastragenol Inhibits Osteoclast Activity in Glucocortico
2026-07-09
This study reveals that cycloastragenol prevents bone loss in a rat model of glucocorticoid-induced osteonecrosis of the femoral head by inhibiting osteoclast activity and modulating osteoclastogenic gene expression. The findings highlight a promising hip-preservation strategy and elucidate molecular mechanisms underlying steroid-induced bone pathology.
-
Standardized Whole-Blood Stimulation for Immunometabolic Ana
2026-07-09
This study introduces a rigorously standardized protocol for analyzing immune responses in human whole blood under metabolic modulation. Its innovation enables reproducible assessment of cytokine production in response to targeted metabolic interventions, advancing immunometabolic research and translational assay design.